Cargando…
Dexamethasone-Induced Perturbations in Tissue Metabolomics Revealed by Chemical Isotope Labeling LC-MS Analysis
Dexamethasone (Dex) is a synthetic glucocorticoid (GC) drug commonly used clinically for the treatment of several inflammatory and immune-mediated diseases. Despite its broad range of indications, the long-term use of Dex is known to be associated with specific abnormalities in several tissues and o...
Autores principales: | Dahabiyeh, Lina A., Malkawi, Abeer K., Wang, Xiaohang, Colak, Dilek, Mujamammi, Ahmed H., Sabi, Essa M., Li, Liang, Dasouki, Majed, Abdel Rahman, Anas M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074358/ https://www.ncbi.nlm.nih.gov/pubmed/31973046 http://dx.doi.org/10.3390/metabo10020042 |
Ejemplares similares
-
Metabolomics Based Profiling of Dexamethasone Side Effects in Rats
por: Malkawi, Abeer K., et al.
Publicado: (2018) -
Metabolomics Profiling of Cystic Renal Disease towards Biomarker Discovery
por: Sriwi, Dalia, et al.
Publicado: (2021) -
Proteomic Analysis of Morphologically Changed Tissues after Prolonged Dexamethasone Treatment
por: Malkawi, Abeer K., et al.
Publicado: (2019) -
Isotopic labeling-assisted metabolomics using LC–MS
por: Bueschl, C., et al.
Publicado: (2012) -
Metabolomics profiling distinctively identified end-stage renal disease patients from chronic kidney disease patients
por: Dahabiyeh, Lina A., et al.
Publicado: (2023)